Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Papillomaviridae

ABSTRACT: Human papillomavirus Genome sequencing

PROVIDER: PRJNA242494 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR1201850_1.fastq.gz	Fastqsanger.gz
	SRR1201850_2.fastq.gz	Fastqsanger.gz
	SRR1201841_1.fastq.gz	Fastqsanger.gz
	SRR1201841_2.fastq.gz	Fastqsanger.gz
	SRR1201851_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 36

Similar Datasets

Human Papillomavirus strain:HPV16

Project description:Human Papillomavirus strain:HPV16 Genome sequencing

| PRJNA240947 | ENA

Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples

Project description:The study is intended to collect specimens to support the application of genome analysis technologies, including large-scale genome sequencing. This study will ultimately provide cancer researchers with specimens that they can use to develop comprehensive catalogs of genomic information on at least 50 types of human cancer. The study will create a resource available to the worldwide research community that could be used to identify and accelerate the development of new diagnostic and prognostic markers, new targets for pharmaceutical interventions, and new cancer prevention and treatment strategies. This study will be a competitive enrollment study conducted at multiple institutions.

| 2140168 | ecrin-mdr-crc

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Human Papillomavirus _Yucatán_Mexico_2

| PRJNA506460 | ENA

Project description:Human Papillomavirus _Yucatán_Mexico_1

| PRJNA506459 | ENA

Human papillomavirus

Project description:Human papillomavirus genotyping

| PRJNA357586 | ENA

Inducible mucosa-like differentiation of head and neck cancer cells drives the epigenetically determined loss of cell malignancy

Project description:Human papillomavirus-negative head and neck squamous cell carcinoma (HNSCC) is a highly malignant disease with high death rates that have remained substantially unaltered for decades. Therefore, new treatment approaches are urgently needed. Human papillomavirus-negative tumors harbor areas of terminally differentiated tissue that are characterized by cornification. Dissecting this intrinsic ability of HNSCC cells to irreversibly differentiate into non-malignant cells may have striking tumor-targeting potential.

2024-08-15 | GSE274251 | GEO

Viral integration transforms chromatin to drive oncogenesis

Project description:We report that the integration of the human papillomavirus into the host genome increases chromatin accessibility, transcription, and CTCF binding within 100 kbp of the integration site which promotes oncogenesis in some patients.

2020-02-14 | GSE143026 | GEO

HPV8 mediated alterations of cellular gene expression

Project description:We expressed either only the E7 oncoprotein or the complete early genome region (CER) of the human papillomavirus type 8 in primary human adult skin keratinocytes. Cells were retrovirally transduced, selected, and cellular mRNA was extracted after expansion of the transgene positive keratinocytes.

2019-07-04 | GSE133813 | GEO

Betapapillomavirus 3

Project description:Human papillomavirus 49 overview

| PRJNA69683 | ENA